Based on the timing of ERK activation and transcriptional activation of known FGF target genes, early gastrula stage 10.5 (11 hours of culture at 23°C) was chosen as the stage for the analysis of FGF targets.
These readings and discussions set the stage for the analysis of two full-length papers.
Notably, these techniques and tools are not restricted to EGFR analysis and also set the stage for the analysis of future therapeutic targets.
We will first present how community members described the various health providers they consulted to set the stage for the analysis on the dimensions of factors influencing healthcare-seeking including uncertainty.
We investigated four statistical models (unadjusted, standardized, adjusted, and two-stage) for the analysis of hypothesized PCB exposure, serum lipids, and a health outcome (breast cancer), along with eight plausible DAGs for each model to illustrate the choices facing investigators.
Using a simulation study, we evaluated four statistical models (unadjusted, standardized, adjusted, and two-stage) for the analysis of PCB exposure, serum lipids, and health outcome risk (breast cancer).
Notably, no fully acceptable protocol exists for microarray data processing, and the different methods used for subsequent stages of the analysis pipeline may result in substantially different results.
We used Stata version 10 for all stages of the analysis[ 24].
These networks were similar to the (bilateral) hippocampal network previously identified using fMRI (Supporting Information Fig. 1B) and used for subsequent stages of the analysis.
Coding was reviewed at several stages of the analysis, allowing for data to be contextualised, and different interpretations explored and resolved through consensus.
